Skip to contentI
InfuSystem Holdings, Inc
I
INFUInfuSystem Holdings, Inc Q2 2018 · 10-Q
Revenue$16.42M$16.42M−3.1% vs Q2 2017 Net Income-$505.00K-$505.00KN/M vs Q2 2017 EPS Diluted-$0.02-$0.02N/M vs Q2 2017 Gross Profit$9,686,000−6.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InfuSystem Holdings, Inc · CIK 1337013 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,793,000+41.9% Free Cash Flowderived$2,170,000+20.9% Margins · derivedGross margin59.0%−2.0 pt vs Q2 2017
Operating margin-1.2%+5.2 pt vs Q2 2017
Net margin-3.1%+3.5 pt vs Q2 2017
ended Jun 30, 2018 · filed Aug 14, 2018 · 45 d after period end